Moderna | MRNA - Sales Revenues


Moderna reported $389M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Acadia Pharmaceuticals USD 268.06M 15.94M Mar/2026
Agios Pharmaceuticals USD 18.8M 1.17M Mar/2026
Alnylam Pharmaceuticals USD 1.17B 70M Mar/2026
Amgen USD 8.62B 1.28B Mar/2026
Arrowhead Research USD 73.74M 190.29M Mar/2026
Biogen USD 2.25B 30M Mar/2026
BioMarin Pharmaceutical USD 766M 109M Mar/2026
Celltrion KRW 1.24T 90B Jun/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 28.31B 2.27B Mar/2026
Gilead Sciences USD 7B 930M Mar/2026
GlaxoSmithKline GBP 7.63B 991M Mar/2026
Incyte USD 1.27B 240M Mar/2026
Ionis Pharmaceuticals USD 246M 43M Mar/2026
Kangmei Pharma CNY 1.08B 288.27M Mar/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Moderna USD 389M 289M Mar/2026
Organigram Holdings CAD 59.79M 3.74M Mar/2026
Pharma Mar EUR 42.9M 47.3M Mar/2026
Puma Biotechnology USD 80.54M 33.46M Sep/2024
Qiagen NV USD 419.22M 38.16M Mar/2026
Regeneron Pharmaceuticals USD 3.6B 280M Mar/2026
Sangamo BioSciences USD 356K 125K Jun/2024
Sarepta Therapeutics USD 730.8M 287.9M Mar/2026
Sartorius EUR 899.1M 28.5M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Tilray USD 217.51M 74.75M Dec/2025
Ultragenyx Pharmaceutical USD 136M 71M Mar/2026
United Therapeutics USD 781.5M 8.7M Mar/2026
Vertex Pharmaceuticals USD 2.99B 200M Mar/2026
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026